EGFR and neoplasm: In contrast to the aforementioned studies, the results obtained in the current study suggest that peritoneal ADSCs can utilize EVs to deliver EGFR signaling molecules to reprogram the proliferative and migratory properties of tumor cells, promoting OC progression and metastasis.